1-CYCLOPROPYL-3-((E)-((8S,11R,13S,14S,17S)-11-(4-CYCLOPROPYLPHENYL)-17-(1,1-DIFLUOROPROP-2-YNYL)-17-HYDROXY-13-METHYL-1,2,6,7,8,11,12,14,15,16-DECAHYDROCYCLOPENTA(A)PHENANTHREN-3-YLIDENE)AMINO)UREA
UNII ZN97X5K9WT
Substance Identification & Data
This profile provides standardized clinical and technical data for 1-cyclopropyl-3-((e)-((8s,11r,13s,14s,17s)-11-(4-cyclopropylphenyl)-17-(1,1-difluoroprop-2-ynyl)-17-hydroxy-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta(a)phenanthren-3-ylidene)amino)urea, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZN97X5K9WT.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3065138-43-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C34H39F2N3O2 PCTMYPHOHLQWLV-BIAAPNPWSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1-cyclopropyl-3-((e)-((8s,11r,13s,14s,17s)-11-(4-cyclopropylphenyl)-17-(1,1-difluoroprop-2-ynyl)-17-hydroxy-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta(a)phenanthren-3-ylidene)amino)urea. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.